Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Albertsons Companies reported yesterday and the reaction has been swift on two fronts: short sellers extended their position to its highest level of the recent run, and three analysts moved their targets on the same day, pulling in opposite directions.
Short interest reached 11.0% of the free float as of October 13, with 60.6 million shares short. That is up nearly 12% on the week and around 19% over the past month, continuing the steady accumulation that featured in prior notes. The ORTEX short score edged to 69.3, its highest reading in the tracked window. Despite the persistent short build, the borrow market remains loose. Cost to borrow is just 0.52%, essentially unchanged from a week ago. Availability is running at 236% of current short interest, well above its 52-week trough of 211%, meaning roughly two and a third shares remain available to lend for every one already borrowed. Shorts are building with conviction, not under any mechanical pressure. The put/call ratio of 0.30 is only slightly above its 20-day mean of 0.29 and sits close to the 52-week low of 0.22, so options positioning still leans constructively, the same divergence between short sellers and options traders that has characterised this stock for weeks.
The analyst response to yesterday's print crystallised the bull-bear divide. RBC Capital raised its target from $13 to $16, keeping its Outperform rating, making the most bullish call on the Street. Wells Fargo moved in the same direction, lifting its target from $11 to $12, though it stayed at Equal-Weight. Bank of America moved the other way entirely, cutting from Neutral to Underperform and trimming its target to $12 from $16. The overall consensus sits at Hold, with 10 holds and 2 underperforms among rated analysts, and a mean price target of $14.19 against a current price of $12.72. The bull case rests on digital profitability, the first such quarter the company has reported, 13% digital sales growth, and management's expectation that identical sales trends improve toward flat and then positive over the next two years. Bears point to a gross margin expected to slip 30 basis points, EBITDA contraction of roughly 6% year-on-year, and limited visibility on when the top-line recovery actually arrives in reported numbers. The EV/EBITDA multiple of 5.9x and PE near 7x reflect the market's caution on that recovery timeline. Forward EPS momentum over 12 months ranks in the 94th percentile of the universe, a bright spot in an otherwise muted factor profile, with short score rank in just the 7th percentile.
The insider picture provides a contrasting data point. In late July, the CEO Susan Morris purchased 39,409 shares across two transactions at around $11.45, totalling roughly $450,000. The CFO Sharon McCollam bought a further 9,000 shares at $11.48. EVP Thomas Moriarty made the largest single purchase, acquiring 170,500 shares at $11.51 for just under $2 million. All three were open-market purchases with no 10b5-1 plan declared, an uncommon cluster of discretionary buying at the executive level. The net insider position over 90 days is 218,909 shares bought for approximately $2.5 million. That buying occurred when the stock was trading in the $11.40 to $11.50 range; the stock closed at $12.72 yesterday, up 11% on the week.
On the institutional register, Cerberus Capital Management holds 31.3% of shares, a position that has not changed recently and represents a controlling-level stake. BlackRock lifted its position by 1.3 million shares to 8.9% of shares in the latest filing period. The Vanguard Group's Schedule 13G/A shows it reduced its disclosed stake to zero as of March 2026, down from 7.16% previously. FMR LLC similarly filed a reduction, moving from 6.8% to 4.5% as of November 2025. Both are passive holders, and once a filer drops below the 5% reporting threshold, no further filing is required, so those positions may have continued to move.
The next earnings event is scheduled for October 27. With short interest at 11% of the float, analyst opinion freshly divided across the same one-session window, and insider buyers sitting on a two-week gain of roughly 11%, the question heading into that print is whether the digital growth story and any further signal on identical sales trajectory is enough to shift the tone for the half of the Street still sitting on the fence.
See the live data behind this article on ORTEX.
Open ACI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
